DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Estrogen Treatment in Acromegalic Women

Information source: Université de Montréal
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Acromegaly

Intervention: Alesse (Drug)

Phase: Phase 2

Status: Recruiting

Sponsored by: Université de Montréal

Official(s) and/or principal investigator(s):
Omar Serri, MD, Principal Investigator, Affiliation: CHUM- Endocrinology

Overall contact:
Omar SERRI, MD, Phone: 514-890-8000, Ext: 25607, Email: omar.serri@umontreal.ca


Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind

Detailed description: This will be a canadian multicenter study with a randomized, double-blind, placebo-controlled design, to assess the efficacy and safety of adjuvant alesse in female acromegalic patients with suboptimal response to sandostatin LAR treatment.


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.


Inclusion Criteria:

- Women 18 years and older treated with somatostatin analogs

- Active acromegaly

Exclusion Criteria:

- Cardiovascular or cerebrovascular disease

- Thrombophlebitis or thromboembolism

- Breast cancer

- Non-controlled arterial hypertension

- Smoking

- Pregnancy or lactation

Locations and Contacts

Omar SERRI, MD, Phone: 514-890-8000, Ext: 25607, Email: omar.serri@umontreal.ca

CHUM - Notre-Dame Hospital, Montreal, Quebec H2L 4M1, Canada; Recruiting
Omar Serri, MD, Principal Investigator
Additional Information

Starting date: May 2006
Last updated: May 25, 2006

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017